Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study

TY - JOUR

T1 - Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT)

T2 - a case-control study

N1 - Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85131701282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131701282&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(22)00045-5

DO - 10.1016/S2213-2600(22)00045-5

M3 - Article

C2 - 35227416

AN - SCOPUS:85131701282

SN - 2213-2600

VL - 10

SP - 566

EP - 572

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 6

ER -